Soputro Nicolas A, Ramos-Carpinteyro Roxana, Chavali Jaya S, Pedraza Adriana M, Mikesell Carter D, Kaouk Jihad
Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH, USA.
BJU Int. 2025 Feb;135(2):249-259. doi: 10.1111/bju.16483. Epub 2024 Jul 25.
To evaluate the different perioperative variables that may serve as important clinical predictors when selecting patients for outpatient single-port robot-assisted radical prostatectomy (SP-RARP).
A retrospective review was performed on the Institutional Review Board-approved, prospectively maintained database to identify 485 consecutive patients who underwent SP-RARP between 2018 and 2023. A comparison analysis was performed on patients who were managed as outpatients vs inpatients following their respective SP-RARP. A separate analysis was performed after excluding patients with pre-planned admissions to identify the risk factors for unplanned admissions.
All procedures were successfully completed without any conversion or additional ports. After excluding patients with pre-planned admissions, outpatient SP-RARP was successfully achieved in 86.6% with a median (interquartile range) length of stay of 4.6 (3.8-6.1) hours. Our multivariate regression analysis identified cardiac comorbidity and preoperative International Prostate Symptom Score (IPSS) as predictors of outpatient SP-RARP. In addition, the absence of cardiac comorbidity, previous abdominal surgery, and lower postoperative pain score were protective against the risk of unplanned admission. Furthermore, both inpatient and outpatient encounters had comparable 90-day rates of postoperative complication (P = 0.136) and hospital re-admission (P = 0.942).
Outpatient management models could be successfully achieved in most patients who underwent SP-RARP (86.6%) while maintaining similarly low perioperative morbidity profile. Nevertheless, appropriate patient selection based on the baseline clinicodemographic characteristics remains essential to ensure the safety and ongoing success of outpatient SP-RARP.
评估在选择患者进行门诊单孔机器人辅助根治性前列腺切除术(SP-RARP)时,可能作为重要临床预测指标的不同围手术期变量。
对机构审查委员会批准的、前瞻性维护的数据库进行回顾性分析,以确定2018年至2023年间连续接受SP-RARP的485例患者。对SP-RARP术后作为门诊患者与住院患者管理的患者进行比较分析。在排除预先计划入院的患者后进行单独分析,以确定意外入院的危险因素。
所有手术均成功完成,无任何中转或增加切口。排除预先计划入院的患者后,86.6%的患者成功进行了门诊SP-RARP,中位(四分位间距)住院时间为4.6(3.8-6.1)小时。我们的多因素回归分析确定心脏合并症和术前国际前列腺症状评分(IPSS)是门诊SP-RARP的预测指标。此外,无心脏合并症、既往腹部手术史以及较低的术后疼痛评分可降低意外入院风险。此外,住院和门诊患者的术后90天并发症发生率(P = 0.136)和再次住院率(P = 0.942)相当。
大多数接受SP-RARP的患者(86.6%)可以成功实现门诊管理模式,同时保持相似的低围手术期发病率。然而,根据基线临床人口统计学特征进行适当的患者选择对于确保门诊SP-RARP的安全性和持续成功仍然至关重要。